STUDresearch · Peptide
Colivelin
Also known as
CLN · ADNF-derived peptide · colivelin peptide
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Peptide
Niche talk
Systemic
SubQ / nasal discussion
Cognitive / nootropic peptides
Systemic preclinical peptide in central/peripheral injection models; capsule/pin and organ-targeting language is older lore, not established human delivery.
What people say
Colivelin is a synthetic ADNF-9–Humanin hybrid studied in cells and rodents for neuroprotection. It is not a Khavinson organ bioregulator, and human cognitive benefit is unestablished.
Doses people talk about
The retained microgram figure is unverified niche community talk. Mouse µg/kg injections are species-specific experiment conditions, not a human conversion.
How it may feel
No completed Colivelin self-use log or human feel sequence appeared in the bounded source set. Promotional claims and mouse outcomes cannot tell a reader what a dose feels like.
Unverified human talk~100–300 mcg; SC discussion
Historical niche class amount with no stated frequency or consensus; not validated by a completed Colivelin user log. Nasal discussion has no matched amount in these notes.
Half-life & effect duration
- Half-life in the body
- Half-lifeNo settled estimate
- Felt duration people report
- Felt durationNo consistent firsthand timeline reported
Cycles people discuss
Older notes carry 10–20-day courses repeated a few times per year and weeks-on/weeks-off bioregulator lore, often framed around cost and caution. This is preserved cultural context, not a validated human Colivelin cycle; the inspected experiments were in mice.
Timing
The retained discussion frames timing around side effects, training and sleep, rather than a preferred clock time. Those are general research-community considerations, not an established Colivelin morning, evening or meal schedule.
Stacks
Earlier notes mention multi-bioregulator combinations, but without human Colivelin logs a solo-versus-stack comparison remains attribution advice rather than evidence of a common regimen.
Watch for
Unknowns: Long-term safety for gray-market preparations is often poorly characterized.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
The inspected primary studies do not establish a human or transferable parent-peptide terminal half-life.
They report cell exposure and timed mouse injections with biological endpoints, including acute and seven-day designs; none is a clearance study.
Species, disease model, route and endpoint differ. Administration intervals cannot be converted into human half-life or a regimen.
- Development of a Femtomolar-Acting Humanin Derivative Named Colivelin by Attaching Activity-Dependent Neurotrophic Factor to Its N Terminus: Characterization of Colivelin-Mediated Neuroprotection against Alzheimer's Disease-Relevant Insults In Vitro and In Vivo (opens in a new tab)Abstract, methods and results: synthetic ADNF-9 fused to an AGA-(C8R)HNG17 Humanin derivative; cell assays plus intracerebroventricular and intraperitoneal mouse memory models.Preclinical cell and mouse work; no human dosing, subjective experience or pharmacokinetic clearance measurement. Central and intraperitoneal animal administration do not establish consumer routes.
- Colivelin, a synthetic derivative of humanin, ameliorates endothelial injury and glycocalyx shedding after sepsis in mice (opens in a new tab)Mouse CLP sepsis experiments: intraperitoneal 100–200 µg/kg at one hour for acute endpoints and subcutaneous 100 µg/kg at 1, 3 and 24 hours for seven-day outcomes.Mouse disease model; timing reflects experimental administration and endpoint design, not human clearance, a felt window or a human regimen.
Felt duration people report
No dependable human felt-duration account was identified in the bounded inspection.
The accessible community item promoted mechanisms and a vendor product but did not report an actual use, amount, effect, null result or same-author follow-up.
This is bounded source coverage, not proof that no report exists anywhere; promotional interest cannot stand in for lived experience.
- Pure Rawz Colivelin (opens in a new tab)OP lines 18–25: promotional description of purported neuroprotective mechanisms and product availability; no completed self-use dose, outcome or follow-up log.Promotional/affiliate-style post, not an independent experience report; mechanism claims are not human efficacy evidence.
What people say
- What is thinner: Large modern multi-center RCTs are often absent for the specific peptide brand story. forum
- Focus / clarity talk: Colivelin shows up in threads about attention, mental fatigue, or “brain fog” days. forum
- Mood adjacency: Some logs mention motivation or anxiety edge changes — highly confounded by caffeine/sleep/stim stacks. anecdote
- Acute vs course: Nasal/SC nootropics often judged same-day; multi-week courses are for “is this real” reassessment. forum
- Neuroprotection hypothesis: Colivelin protected cultured neurons and altered memory/injury endpoints in rodent models through ADNF/CaMKIV- and Humanin/STAT3-linked pathways. This is not human cognitive-benefit evidence. animallab
Doses people talk about
- Human talk: niche experimental logs sometimes cite ~100–300 mcg class amounts without consensus. forum
- Cycle: short experimental blocks more common than multi-month validated use. forum
- Route: SC/experimental; not an approved cognitive drug chart. forum
- Framing: ADNF-9–Humanin hybrid research peptide; preclinical-heavy. animal
How it may feel
- Days 1–7: Earlier generic peptide notes describe site reactions if injected or GI/mood shifts if oral as dominating before benefits. That route-specific symptom sequence is not established for Colivelin by the inspected sources: mouse injection studies are not human logs, and the community page was promotional. forumanimal
- Courses: Earlier notes describe 10–20-day courses repeated a few times per year in broad bioregulator culture, not an established Colivelin schedule. The inspected primary work used acute and seven-day mouse designs. forumanimal
- Days 2–7: Earlier notes describe a side-effect window for many agents and warn that benefits, if any, are easy to misattribute. This is generic context, not an established human Colivelin sequence. forum
- Weeks 1–2: Earlier notes call this a first checkpoint in generic self-logs; the inspected Colivelin sources do not validate that checkpoint or establish a human benefit window. forum
- Day 1: Earlier generic self-log framing emphasizes logistics (route, sting, GI) over a “miracle” effect. It does not establish what most people notice from Colivelin; the bounded source set contained no completed human use log. forum
Cycles people discuss
- Course culture: Short-on, long-off and seasonal-repeat language in the earlier notes describes generic bioregulator culture; it is not a validated Colivelin cycle. forum
- On/off discussion: Earlier notes mention weeks-on / weeks-off self-protocols rather than indefinite daily use, driven more by cost and caution than hard science. The inspected Colivelin sources do not establish this as a common compound-specific pattern or validate chronic human use. forum
- No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
- Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum
Timing
- Short-peptide timing lore: Earlier notes assume rapid clearance and place course timing above steady plasma levels. Neither inference supplies a Colivelin human half-life; the inspected cell and mouse studies did not report a transferable terminal-clearance estimate. forumanimal
- Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
- Acute-window discussion: Earlier nasal/SC nootropic notes describe judging effects within hours and sparse true half-life data for analogs. Those are generic judgments, not established Colivelin felt duration. Central, intraperitoneal and subcutaneous mouse experiments measured biological endpoints, not human nasal/SC clearance. forumanimal
More on what it is
- Evidence honesty: Much of the English-web discussion is secondary summaries and vendor literature; treat claims cautiously. forum
- Research posture: Educational summary of public discussion and literature themes only. forum
- How people talk about it: Forum volume is a popularity signal for Colivelin, not proof it works for you. forum
- What it is: Colivelin is a 26-amino-acid synthetic hybrid of ADNF-9 and a potent Humanin derivative, built for neuroprotection experiments. It is not a Khavinson/cytomedine organ bioregulator. animallab
- Research only: Not approved advice for self-experimentation; legality and access vary by place. forum
Stacks
- Multi-bioregulator stacks: Often combined by organ system in protocols. forum
- Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum
Storage notes
- No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
- Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum
Watch for
- Generally mild claims: Vendor literature often claims good tolerability — independent long-term data limited. forum
- Allergy / unknown impurities: Gray-market risk. forum
- Injection site (if injected): Redness, itch, lumps, bruise — technique and product quality matter. forum
- Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
- Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
- Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum
Evidence mix
Mostly community / anecdote tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.